BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 19c

August 15, 2022 7:05 AM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q2 EPS of ($0.34), $0.19 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

... More